Ensuring absolute biological consistency, batch-to-batch reproducibility, and premium purity levels for diagnostic and clinical testing formulations worldwide.
In contemporary clinical medicine, point-of-care testing (POCT) represents one of the most critical leaps toward fast, precise, and decentralized patient management. Bilirubin, a fundamental breakdown product of hemoglobin catabolism, serves as the definitive clinical indicator for hepatic function, biliary tract integrity, and neonatal hyperbilirubinemia. For newborns, monitoring serum or transcutaneous bilirubin concentration is not simply a metric of health; it is a life-saving screening tool designed to prevent kernicterus—a devastating form of irreversible brain damage caused by severe neonatal jaundice.
Traditional diagnostic procedures require high-volume venous blood sampling followed by centralized clinical laboratory analysis. This process results in significant turnaround delays, exposing high-risk neonates to prolonged periods of toxicity. Point-of-Care Testing (POCT) bilirubin analyzers solve this latency, offering instantaneous readings from micro-samples or non-invasive optical scanning. As an industry-leading OEM POCT Bilirubin factory, we stand at the nexus of diagnostics and biological manufacturing, supplying the high-grade analytical-level bilirubin required to formulate calibration curves, dry chemistry reagent strips, and validation reagents that ensure these medical devices remain accurate to the highest standard.
Information Gain Concept: High-precision diagnostic systems require highly stable standards. Our natural bilirubin extraction methodology maintains molecular configuration integrity, preventing premature photo-degradation—a common failure point in synthetic alternatives.
The manufacturing process of POCT bilirubin standard reference matrices demands a deep understanding of molecular stability. Bilirubin is inherently sensitive to ambient light (photo-isomerization) and oxygen. Global IVD developers choose to partner with experienced manufacturers who can control oxidation kinetics during raw material isolation, ensuring that every batch delivered meets the narrow tolerances necessary for regulatory submissions (FDA, CE, PMDA).
By integrating deep botanical, mammalian, and biological extraction networks across local supply regions in China, we bypass the bottlenecks commonly encountered by Western boutique labs. Large-scale upstream raw material control guarantees constant batch availability.
Our advanced facility maintains strict GMP standards, implementing continuous temperature and light-controlled environmental monitoring. We prevent structural degradation of highly-unstable molecules throughout production.
Every single shipment undergoes strict validation. Through HPLC (High-Performance Liquid Chromatography) mapping and spectrophotometric testing, we guarantee consistent moisture profiles, structural purity, and trace metal absence.
In the global market, pricing pressure remains a major constraint for developers of POCT systems. Sourcing raw materials from a highly integrated Chinese supply chain allows global organizations to drastically reduce their Bill of Materials (BOM) cost without compromising biological efficacy or meeting the technical standards outlined in ISO 15189 and ISO 13485.
Established in 2012, Chenlv Herb is a leading high-tech enterprise specializing in the R&D, production, and sales of botanical extracts and natural pharmaceutical ingredients.
One of the primary challenges faced by global IVD manufacturers when choosing an offshore partner is navigating localization and regulatory compliance. Diagnostic products are subject to stringent oversight by agencies such as the FDA (United States), EMA (Europe), and NMPA (China). In the context of bilirubin POCT devices, which directly impact neonatal clinical pathways, any variance in calibration parameters can trigger recalls, warning letters, or clinical inaccuracies.
To eliminate these compliance bottlenecks, we offer end-to-end regulatory support. This includes providing complete validation documentation, Stability Study Reports (under diverse ICH temperature zones), and comprehensive Drug Master File (DMF) components where applicable. Our production environment complies with ISO 9001 and ISO 22000 quality management standards, making it simple to integrate our calibration standard series directly into your medical device file registration workflow.
We provide full chemistry, manufacturing, and control (CMC) dossiers, certificate of analysis (CoA) detailing impurity profiles, and compliance statements for CE, Halal, Kosher, and FDA registrations.
Bilirubin compounds are highly heat-sensitive. We utilize customized nitrogen-flushed, amber-glass container packaging and validate regional cold-chain distribution to ensure the product arrives structurally sound.
Our state-of-the-art facilities are fully open to third-party safety and operational quality audits. We provide full documentation trace audits to ensure compliance with medical standards.
Diverse implementation pathways for high-grade botanical extracts and natural biochemical compounds.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for the development of health care products due to their natural, green and safe characteristics.
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy the prominent position in the pharmaceutical industry due to their natural active ingredients and unique pharmacological effects.
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new solutions for skin care.
Plant extracts have shown great potential in improving animal health, enhancing production performance and optimizing culture benefits, and are gradually becoming a research hotspot and new favorite in the field of animal nutrition.
How we co-develop and customize precision calibration solutions for international diagnostic companies.
We work with you to define your purity parameters and stabilization requirements.
We provide a clear cost estimation based on scale and regulatory complexity.
We formalize our partnership with clear guarantees on quality and delivery.
Our lab designs trial batches with customized formulation buffers.
We manufacture under strict GMP environments, with light shielding protocols.
Every batch is tested via HPLC, issuing an extensive CoA.
We arrange validated global cold-chain shipment to your warehouse.
Unlike standard off-the-shelf laboratory chemical suppliers, our team recognizes that POCT integration requires unique parameters. For instance, developers building dry chemistry paper strips require different carrier solvents and moisture specifications than developers building microfluidic cartridge wells. By fine-tuning characteristics such as particle size, solvent solubility, and biological conjugation compatibility during the manufacturing phase, we deliver a drop-in component that speeds up your integration timeline.
Our company is certified by ISO9001, ISO22000, HALAL, KOSHER, FDA, and more, proving our commitment to safety and quality.
The global point-of-care diagnostics market is entering a phase of rapid development, driven by advancements in microfluidics, wearable biosensors, and AI-enabled diagnostic networks. For neonatal care, the trend is shifting toward integrated non-invasive transcutaneous bilirubinometers (TcB) and low-sample capillary blood cartridge tests. These innovations help reduce pain and stress in newborn patients, while lowering infection risks in clinical environments.
At the same time, direct spectrophotometry and enzymatic assays (such as bilirubin oxidase methods) are becoming more common in healthcare clinics. This shift has changed the specifications for bilirubin reference standards. Standard calibrators must now work seamlessly across multiple diagnostic technologies, from simple test strips to complex enzymatic solutions. Sourcing high-purity, naturally isolated bilirubin allows developers to design calibration curves that match the natural properties of neonatal blood, minimizing errors caused by synthetic structural differences.
Clinical Focus Note: The integration of POCT systems into home-care settings for high-risk babies is increasing. Reliable calibrators are essential to prevent false negatives, giving families peace of mind and protecting neonatal health.
Find technical insights and answers to common integration questions from our quality control and R&D teams.
Stay informed with the latest insights on market trends, international trade shows, and biochemical innovations.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season comes to an end, price fluctuations remain a focal point.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery.
The 92nd China International Pharmaceutical Raw Materials / Intermediates / Packaging / Equipment Fair (API China) will grandly open at the China Import and Export Fair Exhibition Hall in Guangzhou.
For inquiries about our POCT Bilirubin standard reference materials, plant extracts, or detailed wholesale price lists, please leave your contact details. Our technical sales team will reply within 24 hours.
Contact Our Technical Sales TeamProviding consistent quality, certified safety standards, and reliable logistics for global pharmaceutical and healthcare brands.
Chenlv Herb
